Fig. 1From: Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?Infection durations for 8 hypothetical trial participants (Panel A), information recorded by monthly sampling (Panel B), information incorporated into VERR (Panel C), and information incorporated into VEHR (Panel D)Back to article page